Einzelansicht

[Back]

Univ.-Prof. Dipl. oec. troph. Dr. Ina Bergheim, Privatdoz.

T: +43-1-4277-54981

ina.bergheim@univie.ac.at

Winter term 2024

330019 VO Biochemie

330028 UE Übungen zu Methoden der experimentiellen Ernährungsforschung

330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung

330060 SE Seminar Vertiefende Humanernährung

330062 VO Methoden der experimentellen Ernährungsforschung

330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013

330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt

330115 VO Angewandte und Vertiefende Humanernährung

330120 UE Übungen zu molekularen Arbeitsmethoden in der Ernährungswissenschaft UE 12ECTS

580002 SE PhaNuSpo - Scientific Lectures

Summer term 2024

330021 UE Übungen zur experimentellen Humanernährung

330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung

330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013

330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt

330112 VO Anatomie und Histologie

330120 UE Übung zur Ernährung und Immunfunktion

580002 SE PhaNuSpo - Scientific Lectures

Winter term 2023

330019 VO Biochemie

330028 UE Übungen zu Methoden der experimentiellen Ernährungsforschung

330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung

330060 SE Seminar Vertiefende Humanernährung

330062 VO Methoden der experimentellen Ernährungsforschung

330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013

330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt

330115 VO Angewandte und Vertiefende Humanernährung

330120 UE Übungen zu molekularen Arbeitsmethoden in der Ernährungswissenschaft UE 12ECTS

580002 SE PhaNuSpo - Scientific Lectures

Brandt A , Csarmann K, Hernández-Arriaga A, Baumann A , Staltner R, Halilbasic E et al. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction. The Journal of Nutritional Biochemistry. 2024 Jan;123:109495. doi: 10.1016/j.jnutbio.2023.109495

Brandt A, Hernández-Arriaga A, Yergaliyev T, Nier A, Halilbasic E, Trauner M et al. Short-term intake of fiber-rich oat bran but not spelt bran flake mix lowers bacterial endotoxin levels and improves health parameters in healthy, normal weight, young to middle-aged women. Journal of Functional Foods. 2024 Jan;112:105929. doi: 10.1016/j.jff.2023.105929

Rajcic D, Kromm F, Hernández-Arriaga A, Brandt A , Baumann A , Staltner R et al. Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice. Biomolecules. 2023 Oct 26;13(11):1579. doi: 10.3390/biom13111579

Burger K, Jung F, Baumann A , Brandt A , Staltner R, Sanchez Juarez VM et al. TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice. Redox biology. 2023 Oct;66:102870. doi: 10.1016/j.redox.2023.102870

Staltner R, Sanchez Juarez VM, Bergheim I , Baumann A. Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults-A Randomized Controlled Trial. Nutrients. 2023 Sep 18;15(18):4038. doi: 10.3390/nu15184038

Heller B, Reiter FP, Leicht HB, Fiessler C, Bergheim I, Heuschmann PU et al. Salt-Intake-Related Behavior Varies between Sexes and Is Strongly Associated with Daily Salt Consumption in Obese Patients at High Risk for MASLD. Nutrients. 2023 Sep 12;15(18):3942. doi: 10.3390/nu15183942

Brandt A, Kromm F, Hernández-Arriaga A, Sánchez IM, Bozkir HÖ, Staltner R et al. Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions. Cells. 2023 Aug 27;12(17):2153. doi: 10.3390/cells12172153

Staltner R , Burger K , Baumann A , Bergheim I. Fructose: a modulator of intestinal barrier function and hepatic health? European Journal of Nutrition. 2023 Aug 18;62(8).

Gui W, Hole MJ, Molinaro A, Edlund K, Jørgensen KK, Su H et al. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis. Nature Communications. 2023 Jun 6;14(1):3304. doi: 10.1038/s41467-023-38840-8

Jung F, Sanchez Juarez VM, Brandt A , Bergheim I. Alcohol-related liver disease: also a question of what you drink? Exploration of Digestive Diseases. 2023 Feb.

Brandt A , Baumann A, Hernández-Arriaga A, Jung F, Nier A, Staltner R et al. Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and `inflammaging. Redox biology. 2022 Dec;58:102528. doi: https://doi.org/10.1016/j.redox.2022.102528

Jung F, Staltner R, Tahir A, Baumann A , Burger K, Halilbasic E et al. Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs. European Journal of Nutrition. 2022 Dec;61(8):4155-4166. doi: 10.1007/s00394-022-02964-2

Jung F, Staltner R , Baumann A , Burger K, Halilbasic E, Hellerbrand C et al. A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women. International Journal of Molecular Sciences. 2022 Oct 21;23(20):12702. doi: 10.3390/ijms232012702

Baumann A , Brandt A , Bergheim I. Fructose, a trigger of metabolic disease? – a narrative review. Exploration of Digestive Diseases. 2022 Aug 29;(1):51-71.

Montez De Sousa I, Bergheim I, Brombach C. Beyond the Individual – A Scoping Review and Bibliometric Mapping of Ecological Determinants of Eating Behavior in Older Adults. Public Health. 2022 Aug 3;43(43):1604967. doi: 10.3389/phrs.2022.1604967

Baumann A , Burger K , Staltner R, Jung F, Rajcic D, Lorenzo Pisarello MJ et al. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease. Metabolism. 2022 Aug;133:155233. Epub 2022 May 30. doi: 10.1016/j.metabol.2022.155233

Zieger E , Schwaha T, Burger K, Bergheim I , Wanninger A, Calcino AD. Midbody-Localized Aquaporin Mediates Intercellular Lumen Expansion During Early Cleavage of an Invasive Freshwater Bivalve. Frontiers in cell and developmental biology. 2022 Jun 14;10:894434. doi: 10.3389/fcell.2022.894434

Untersmayr E, Brandt A, Koidl L, Bergheim I. The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging. Nutrients. 2022 Feb 23;14(5):949. doi: 10.3390/nu14050949

Baumann A, Rajcic D, Brandt A, Sanchez Juarez VM, Jung F, Staltner R et al. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine. 2022 Feb;26(4):1206-1218. doi: https://doi.org/10.1111/jcmm.17175

Jung F, Brandt A , Bergheim I. Intestinal barrier and pathogen-associated molecular patterns (PAMPs) in the development and therapy of alcohol-related liver disease. In Mueller S, Heilig M, editors, Alcohol and alcohol-related diseases. Springer. 2022